Loading…
Variable Bcl-2 phenotype in benign and malignant lesions of urothelium
We examined Bcl-2, Bax and p53 expression in transitional epithelium, benign lesions derived from transitional epithelium (Brunn's nests and inverted papillomas) and transitional cell cancer (TCC) of the upper urinary tract and urinary bladder using immunostaining of cryostat sections. We also...
Saved in:
Published in: | Cancer letters 1998-06, Vol.128 (1), p.87-92 |
---|---|
Main Authors: | , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c420t-1a257e4725af3174cf45b691e3f15be1f93b3460f0f15e5415aba27d6c2a0ff33 |
---|---|
cites | cdi_FETCH-LOGICAL-c420t-1a257e4725af3174cf45b691e3f15be1f93b3460f0f15e5415aba27d6c2a0ff33 |
container_end_page | 92 |
container_issue | 1 |
container_start_page | 87 |
container_title | Cancer letters |
container_volume | 128 |
creator | Bilim, Vladimir N Tomita, Yoshihiko Kawasaki, Takashi Takeda, Masayuki Takahashi, Kota |
description | We examined Bcl-2, Bax and p53 expression in transitional epithelium, benign lesions derived from transitional epithelium (Brunn's nests and inverted papillomas) and transitional cell cancer (TCC) of the upper urinary tract and urinary bladder using immunostaining of cryostat sections. We also performed Western blot analysis of normal urothelium and TCCs for Bcl-2 and p53. Immunohistochemical staining showed that Bcl-2 was expressed only on basal layer cells, whereas Bax expression was restricted to superficial layers in normal transitional epithelium. Benign lesions of the urinary bladder (Brunn's nests and inverted papillomas) showed strong immunoreactivity to Bcl-2. Taken together, 16 (17%) TCCs were positive for Bcl-2, 62 (64.6%) TCCs were positive for Bax and 28 (29%) TCCs were positive for p53. The expression of Bcl-2 on TCC had a statistical correlation with tumor stage, histopathologic grade and p53 protein accumulation. The results suggest that although Bcl-2 overexpression is detected in normal urothelium and benign lesions of the urinary bladder, it might also contribute to the high grade tumor malignancy of TCC. |
doi_str_mv | 10.1016/S0304-3835(98)00055-X |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_79980234</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S030438359800055X</els_id><sourcerecordid>17128053</sourcerecordid><originalsourceid>FETCH-LOGICAL-c420t-1a257e4725af3174cf45b691e3f15be1f93b3460f0f15e5415aba27d6c2a0ff33</originalsourceid><addsrcrecordid>eNqFkE1P3DAQhi0E2m63_QlIPiBEDyn-jJMTAlTaSkgcoBU3y3HGrCvHWeyk0v57sh-C45481jzz2vMgdErJd0poeflIOBEFr7i8qKtvhBApi-cjNKeVYoWqK3KM5u_IJ_Q5538bSCg5Q7O6lEzVao7u_prkTRMA39hQMLxaQuyH9Qqwj7iB6F8iNrHFnQlTaeKAA2Tfx4x7h8fUD0sIfuy-oBNnQoav-3OB_tz9eLr9Vdw__Px9e31fWMHIUFDDpAKhmDSOUyWsE7IpawrcUdkAdTVvuCiJI9MdpKDSNIaptrTMEOc4X6DzXe4q9a8j5EF3PlsIwUTox6xVPS3OuDgIUkVZReQmUe5Am_qcEzi9Sr4zaa0p0RvReitabyzqutJb0fp5mjvdPzA2HbTvU3uzU_9s3zfZmuCSidbnj_CSU8LIhF3tMJis_feQdLYeooXWJ7CDbnt_4CNvBYGZFA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17128053</pqid></control><display><type>article</type><title>Variable Bcl-2 phenotype in benign and malignant lesions of urothelium</title><source>Elsevier</source><creator>Bilim, Vladimir N ; Tomita, Yoshihiko ; Kawasaki, Takashi ; Takeda, Masayuki ; Takahashi, Kota</creator><creatorcontrib>Bilim, Vladimir N ; Tomita, Yoshihiko ; Kawasaki, Takashi ; Takeda, Masayuki ; Takahashi, Kota</creatorcontrib><description>We examined Bcl-2, Bax and p53 expression in transitional epithelium, benign lesions derived from transitional epithelium (Brunn's nests and inverted papillomas) and transitional cell cancer (TCC) of the upper urinary tract and urinary bladder using immunostaining of cryostat sections. We also performed Western blot analysis of normal urothelium and TCCs for Bcl-2 and p53. Immunohistochemical staining showed that Bcl-2 was expressed only on basal layer cells, whereas Bax expression was restricted to superficial layers in normal transitional epithelium. Benign lesions of the urinary bladder (Brunn's nests and inverted papillomas) showed strong immunoreactivity to Bcl-2. Taken together, 16 (17%) TCCs were positive for Bcl-2, 62 (64.6%) TCCs were positive for Bax and 28 (29%) TCCs were positive for p53. The expression of Bcl-2 on TCC had a statistical correlation with tumor stage, histopathologic grade and p53 protein accumulation. The results suggest that although Bcl-2 overexpression is detected in normal urothelium and benign lesions of the urinary bladder, it might also contribute to the high grade tumor malignancy of TCC.</description><identifier>ISSN: 0304-3835</identifier><identifier>EISSN: 1872-7980</identifier><identifier>DOI: 10.1016/S0304-3835(98)00055-X</identifier><identifier>PMID: 9652797</identifier><identifier>CODEN: CALEDQ</identifier><language>eng</language><publisher>Shannon: Elsevier Ireland Ltd</publisher><subject>Adult ; Aged ; Apoptosis ; Bax ; Bcl-2 ; bcl-2-Associated X Protein ; Biological and medical sciences ; Carcinoma, Transitional Cell - genetics ; Carcinoma, Transitional Cell - metabolism ; Female ; Gene Expression ; Humans ; Male ; Medical sciences ; Middle Aged ; Nephrology. Urinary tract diseases ; p53 ; Proto-Oncogene Proteins - metabolism ; Proto-Oncogene Proteins c-bcl-2 - metabolism ; Transitional cell cancer ; Tumor Suppressor Protein p53 - metabolism ; Tumors of the urinary system ; Urinary Bladder Neoplasms - genetics ; Urinary Bladder Neoplasms - metabolism ; Urinary tract. Prostate gland ; Urogenital Neoplasms - metabolism ; Urothelium - metabolism</subject><ispartof>Cancer letters, 1998-06, Vol.128 (1), p.87-92</ispartof><rights>1998 Elsevier Science Ireland Ltd</rights><rights>1999 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c420t-1a257e4725af3174cf45b691e3f15be1f93b3460f0f15e5415aba27d6c2a0ff33</citedby><cites>FETCH-LOGICAL-c420t-1a257e4725af3174cf45b691e3f15be1f93b3460f0f15e5415aba27d6c2a0ff33</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=1631020$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9652797$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bilim, Vladimir N</creatorcontrib><creatorcontrib>Tomita, Yoshihiko</creatorcontrib><creatorcontrib>Kawasaki, Takashi</creatorcontrib><creatorcontrib>Takeda, Masayuki</creatorcontrib><creatorcontrib>Takahashi, Kota</creatorcontrib><title>Variable Bcl-2 phenotype in benign and malignant lesions of urothelium</title><title>Cancer letters</title><addtitle>Cancer Lett</addtitle><description>We examined Bcl-2, Bax and p53 expression in transitional epithelium, benign lesions derived from transitional epithelium (Brunn's nests and inverted papillomas) and transitional cell cancer (TCC) of the upper urinary tract and urinary bladder using immunostaining of cryostat sections. We also performed Western blot analysis of normal urothelium and TCCs for Bcl-2 and p53. Immunohistochemical staining showed that Bcl-2 was expressed only on basal layer cells, whereas Bax expression was restricted to superficial layers in normal transitional epithelium. Benign lesions of the urinary bladder (Brunn's nests and inverted papillomas) showed strong immunoreactivity to Bcl-2. Taken together, 16 (17%) TCCs were positive for Bcl-2, 62 (64.6%) TCCs were positive for Bax and 28 (29%) TCCs were positive for p53. The expression of Bcl-2 on TCC had a statistical correlation with tumor stage, histopathologic grade and p53 protein accumulation. The results suggest that although Bcl-2 overexpression is detected in normal urothelium and benign lesions of the urinary bladder, it might also contribute to the high grade tumor malignancy of TCC.</description><subject>Adult</subject><subject>Aged</subject><subject>Apoptosis</subject><subject>Bax</subject><subject>Bcl-2</subject><subject>bcl-2-Associated X Protein</subject><subject>Biological and medical sciences</subject><subject>Carcinoma, Transitional Cell - genetics</subject><subject>Carcinoma, Transitional Cell - metabolism</subject><subject>Female</subject><subject>Gene Expression</subject><subject>Humans</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Nephrology. Urinary tract diseases</subject><subject>p53</subject><subject>Proto-Oncogene Proteins - metabolism</subject><subject>Proto-Oncogene Proteins c-bcl-2 - metabolism</subject><subject>Transitional cell cancer</subject><subject>Tumor Suppressor Protein p53 - metabolism</subject><subject>Tumors of the urinary system</subject><subject>Urinary Bladder Neoplasms - genetics</subject><subject>Urinary Bladder Neoplasms - metabolism</subject><subject>Urinary tract. Prostate gland</subject><subject>Urogenital Neoplasms - metabolism</subject><subject>Urothelium - metabolism</subject><issn>0304-3835</issn><issn>1872-7980</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1998</creationdate><recordtype>article</recordtype><recordid>eNqFkE1P3DAQhi0E2m63_QlIPiBEDyn-jJMTAlTaSkgcoBU3y3HGrCvHWeyk0v57sh-C45481jzz2vMgdErJd0poeflIOBEFr7i8qKtvhBApi-cjNKeVYoWqK3KM5u_IJ_Q5538bSCg5Q7O6lEzVao7u_prkTRMA39hQMLxaQuyH9Qqwj7iB6F8iNrHFnQlTaeKAA2Tfx4x7h8fUD0sIfuy-oBNnQoav-3OB_tz9eLr9Vdw__Px9e31fWMHIUFDDpAKhmDSOUyWsE7IpawrcUdkAdTVvuCiJI9MdpKDSNIaptrTMEOc4X6DzXe4q9a8j5EF3PlsIwUTox6xVPS3OuDgIUkVZReQmUe5Am_qcEzi9Sr4zaa0p0RvReitabyzqutJb0fp5mjvdPzA2HbTvU3uzU_9s3zfZmuCSidbnj_CSU8LIhF3tMJis_feQdLYeooXWJ7CDbnt_4CNvBYGZFA</recordid><startdate>19980605</startdate><enddate>19980605</enddate><creator>Bilim, Vladimir N</creator><creator>Tomita, Yoshihiko</creator><creator>Kawasaki, Takashi</creator><creator>Takeda, Masayuki</creator><creator>Takahashi, Kota</creator><general>Elsevier Ireland Ltd</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TO</scope><scope>H94</scope><scope>7X8</scope></search><sort><creationdate>19980605</creationdate><title>Variable Bcl-2 phenotype in benign and malignant lesions of urothelium</title><author>Bilim, Vladimir N ; Tomita, Yoshihiko ; Kawasaki, Takashi ; Takeda, Masayuki ; Takahashi, Kota</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c420t-1a257e4725af3174cf45b691e3f15be1f93b3460f0f15e5415aba27d6c2a0ff33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1998</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Apoptosis</topic><topic>Bax</topic><topic>Bcl-2</topic><topic>bcl-2-Associated X Protein</topic><topic>Biological and medical sciences</topic><topic>Carcinoma, Transitional Cell - genetics</topic><topic>Carcinoma, Transitional Cell - metabolism</topic><topic>Female</topic><topic>Gene Expression</topic><topic>Humans</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Nephrology. Urinary tract diseases</topic><topic>p53</topic><topic>Proto-Oncogene Proteins - metabolism</topic><topic>Proto-Oncogene Proteins c-bcl-2 - metabolism</topic><topic>Transitional cell cancer</topic><topic>Tumor Suppressor Protein p53 - metabolism</topic><topic>Tumors of the urinary system</topic><topic>Urinary Bladder Neoplasms - genetics</topic><topic>Urinary Bladder Neoplasms - metabolism</topic><topic>Urinary tract. Prostate gland</topic><topic>Urogenital Neoplasms - metabolism</topic><topic>Urothelium - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bilim, Vladimir N</creatorcontrib><creatorcontrib>Tomita, Yoshihiko</creatorcontrib><creatorcontrib>Kawasaki, Takashi</creatorcontrib><creatorcontrib>Takeda, Masayuki</creatorcontrib><creatorcontrib>Takahashi, Kota</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Cancer letters</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bilim, Vladimir N</au><au>Tomita, Yoshihiko</au><au>Kawasaki, Takashi</au><au>Takeda, Masayuki</au><au>Takahashi, Kota</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Variable Bcl-2 phenotype in benign and malignant lesions of urothelium</atitle><jtitle>Cancer letters</jtitle><addtitle>Cancer Lett</addtitle><date>1998-06-05</date><risdate>1998</risdate><volume>128</volume><issue>1</issue><spage>87</spage><epage>92</epage><pages>87-92</pages><issn>0304-3835</issn><eissn>1872-7980</eissn><coden>CALEDQ</coden><abstract>We examined Bcl-2, Bax and p53 expression in transitional epithelium, benign lesions derived from transitional epithelium (Brunn's nests and inverted papillomas) and transitional cell cancer (TCC) of the upper urinary tract and urinary bladder using immunostaining of cryostat sections. We also performed Western blot analysis of normal urothelium and TCCs for Bcl-2 and p53. Immunohistochemical staining showed that Bcl-2 was expressed only on basal layer cells, whereas Bax expression was restricted to superficial layers in normal transitional epithelium. Benign lesions of the urinary bladder (Brunn's nests and inverted papillomas) showed strong immunoreactivity to Bcl-2. Taken together, 16 (17%) TCCs were positive for Bcl-2, 62 (64.6%) TCCs were positive for Bax and 28 (29%) TCCs were positive for p53. The expression of Bcl-2 on TCC had a statistical correlation with tumor stage, histopathologic grade and p53 protein accumulation. The results suggest that although Bcl-2 overexpression is detected in normal urothelium and benign lesions of the urinary bladder, it might also contribute to the high grade tumor malignancy of TCC.</abstract><cop>Shannon</cop><pub>Elsevier Ireland Ltd</pub><pmid>9652797</pmid><doi>10.1016/S0304-3835(98)00055-X</doi><tpages>6</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0304-3835 |
ispartof | Cancer letters, 1998-06, Vol.128 (1), p.87-92 |
issn | 0304-3835 1872-7980 |
language | eng |
recordid | cdi_proquest_miscellaneous_79980234 |
source | Elsevier |
subjects | Adult Aged Apoptosis Bax Bcl-2 bcl-2-Associated X Protein Biological and medical sciences Carcinoma, Transitional Cell - genetics Carcinoma, Transitional Cell - metabolism Female Gene Expression Humans Male Medical sciences Middle Aged Nephrology. Urinary tract diseases p53 Proto-Oncogene Proteins - metabolism Proto-Oncogene Proteins c-bcl-2 - metabolism Transitional cell cancer Tumor Suppressor Protein p53 - metabolism Tumors of the urinary system Urinary Bladder Neoplasms - genetics Urinary Bladder Neoplasms - metabolism Urinary tract. Prostate gland Urogenital Neoplasms - metabolism Urothelium - metabolism |
title | Variable Bcl-2 phenotype in benign and malignant lesions of urothelium |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T07%3A19%3A44IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Variable%20Bcl-2%20phenotype%20in%20benign%20and%20malignant%20lesions%20of%20urothelium&rft.jtitle=Cancer%20letters&rft.au=Bilim,%20Vladimir%20N&rft.date=1998-06-05&rft.volume=128&rft.issue=1&rft.spage=87&rft.epage=92&rft.pages=87-92&rft.issn=0304-3835&rft.eissn=1872-7980&rft.coden=CALEDQ&rft_id=info:doi/10.1016/S0304-3835(98)00055-X&rft_dat=%3Cproquest_cross%3E17128053%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c420t-1a257e4725af3174cf45b691e3f15be1f93b3460f0f15e5415aba27d6c2a0ff33%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=17128053&rft_id=info:pmid/9652797&rfr_iscdi=true |